Research programme: eye disorder therapies - AlphaRx
Alternative Names: AL 0155; Binoxan; LT 0155Latest Information Update: 22 Sep 2011
At a glance
- Originator AlphaRx
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Eye disorders; Inflammation
Most Recent Events
- 05 Jul 2011 Discontinued - Preclinical for Bacterial infections in Canada (Ophthalmic)
- 05 Jul 2011 Discontinued - Preclinical for Eye disorders in Canada (Ophthalmic)
- 05 Jul 2011 Discontinued - Preclinical for Inflammation in Canada (Ophthalmic)